INTERNATIONAL PATENT: INNOVENT BIOLOGICS (SUZHOU) CO., LTD., 信达生物制药（苏州）有限公司 FILES APPLICATION FOR "ANTI-PD-L1 AND CD40 BISPECIFIC ANTIBODY AND USE THEREOF"

GENEVA, Sept. 15 -- INNOVENT BIOLOGICS (SUZHOU) CO., LTD. (168 Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 信达生物制药（苏州）有限公司 (中国江苏省苏州市苏州工业园区东平街168号) filed a patent application (PCT/CN2025/080757) for "ANTI-PD-L1 AND CD40 BISPECIFIC ANTIBODY AND USE THEREOF" on Mar 05, 2025. With publication no. WO/2025/185656, the details related to the patent application was published on Sep 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is mana...